Skip to content

Comparison of Robot Assisted Thoracic Surgery With Video Assisted Thoracic Surgery in Case of Lung Cancer

Comparison of Robot Assisted Thoracic Surgery With Video Assisted Thoracic Surgery in Case of Lung Cancer: a Prospective Trial With Control Group

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03152071
Enrollment
30
Registered
2017-05-12
Start date
2017-08-15
Completion date
2018-07-01
Last updated
2017-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Loss, Inflammatory Response, Lung Cancer, Postoperative Pain

Keywords

thoracoscopic surgery, RATS, VATS, Robot

Brief summary

In this study the investigator will compare the effectiveness of robot assisted thoracic surgery (RATS) with video assisted thoracic surgery (VATS) in case of lung cancer. The perioperative circumstances and postoperative outcome will be compared.

Detailed description

Participants are randomly subdivided (1:1) to either undergo robot assisted lobectomy or video assisted thoracoscopic lobectomy in case of lung cancer. At the end of both surgical interventions the anaesthesiologist administers the same technique of pain relief: paravertebral blockage. The data that are going to be investigated are: operative time, conversion to spreading of the ribs/thoracotomy, blood loss, lymph node dissection, prolonged air leak, chest tube drainage, length of stay, inflammatory reaction (through inflammatory parameters CRP, IL-3, IL-6, TNF), lung recuperation (through a lung function test) and postoperative pain (VAS score questionnaire).

Interventions

PROCEDURERobot assited thoracic surgery

The lobectomy will be preformed in case of an operable lung cancer. The thoracic surgery technique used is robot assisted thoracic surgery

PROCEDUREVideo assited thoracic surgery

The lobectomy will be preformed in case of an operable lung cancer. The thoracic surgery technique used is video assisted thoracic surgery.

Sponsors

Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients must be 18 years old or older * Patients can be male or female * Patients with a lung tumour which is treatable with surgery

Exclusion criteria

* Pregnancy * Inoperable lung tumour * Patients which are at risk for general anaesthesia

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain2 months0 = no pain 10 = unbearable pain: VASscore

Secondary

MeasureTime frameDescription
operative timeup to 4 hoursduration of surgery
conversion to spreading of the ribs/thoracotomyup to 4 hours0 = no 1 = yes
lymph node dissectionup to 4 hoursnumber of lymph nodes
prolonged air leakup to 7 dayschest tube present longer than usual
blood lossup to 4 hoursml
length of stayup to 7 daysduration of hospitalisation after surgery
pulmonary function2 monthsrecovery of function of the operated lung
Inflammatory reaction48 hoursthese inflammatory parameters will be determined: C-reactive protein; IL-3; IL-6; TNF
chest tube drainageup to 7 daysml

Countries

Belgium

Contacts

Primary ContactVeerle Van Mossevelde, data nurse
veerle.vanmossevelde@uzbrussel.be+3224763134
Backup ContactDirk De Clippeleir, data nurse
dirk.declippeleir@uzbrussel.be+3224763580

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026